PLx Pharma Inc.
PLx Pharma Inc. (PLXP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
plxp · stock forecast · 5 analysts (3M) · FMP · updated Jul 14, 2025
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Hold
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.01
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.01 | ↑ 0.00% |
1-day model range: $0.01–$0.01. Peak: $0.01 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PLXP · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-08-15 | JMP Securities | Downgrade ↓ | Market Outperform→Perform |
| 2022-08-15 | Oppenheimer | Downgrade ↓ | Outperform→Perform |
| 2022-05-16 | Raymond James | Maintains | Outperform→Outperform |
| 2022-03-14 | Raymond James | Maintains | Outperform→Outperform |
| 2021-12-07 | Raymond James | Upgrade ↑ | Market Perform→Outperform |
| 2021-09-21 | BWS Financial | Maintains | Buy→Buy |
| 2021-04-09 | Oppenheimer | Maintains | Outperform→Outperform |
| 2020-05-18 | JMP Securities | Maintains | Market Outperform→Outperform |
| 2019-03-14 | JMP Securities | Maintains | Market Outperform→Outperform |
| 2019-01-14 | Raymond James | Downgrade ↓ | Outperform→Perform |
Wall Street analysts have recently issued updated ratings on PLx Pharma Inc. (PLXP) stock. Of the recent 12 rating actions, 1 were upgrades and 4 were downgrades. 5 analysts currently cover PLXP.
Analyst Recommendation Trends
PLXP analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast PLXP EPS of $— for the current fiscal year, based on estimates from 0 analysts. The PLXP revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PLXP stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PLXP price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The PLXP short-term stock prediction for tomorrow is $0.01 (+0.00%).
PLx Pharma Inc. trades on NASDAQ under the ticker PLXP. The PLXP stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 40% of covering analysts.
Frequently asked questions
PLXP forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month PLXP price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.